Amgen (AMGN) Offering Possible 7.76% Return Over the Next 7 Calendar Days

This article was originally published on this site

Amgen’s most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $185.00 short put and a strike $180.00 long put offers a potential 7.76% return on risk over the next 7 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $185.00 by expiration. The full premium credit of $0.36 would be kept by the premium seller. The risk of $4.64 would be incurred if the stock dropped below the $180.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.

The RSI indicator is at 65.16 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


Why Regeneron Pharma Won’t Unseat Amgen In Cholesterol Drugs
Wed, 07 Mar 2018 21:41:27 +0000
An analyst said Wednesday that Regeneron’s Praluent is likely to be similar to Amgen’s Repatha in a heart study.

Amgen Announces 2018 Second Quarter Dividend
Wed, 07 Mar 2018 21:15:00 +0000
THOUSAND OAKS, Calif., March 7, 2018 /PRNewswire/ — Amgen (AMGN) today announced that its Board of Directors declared a $1.32 per share dividend for the second quarter of 2018. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives.

Pharmaceutical Industry Outlook – March 2018
Wed, 07 Mar 2018 21:00:09 +0000
Pharmaceutical Industry Outlook – March 2018

Amgen To Present At the Cowen and Company 38th Annual Health Care Conference
Wed, 07 Mar 2018 21:00:00 +0000
THOUSAND OAKS, Calif. , March 7, 2018 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the Cowen and Company 38 th Annual Health Care Conference at 1:30 p.m. ET on Monday, March 12, 2018 , in Boston …

How Bristol-Myers Squibb’s Yervoy Performed in 2017
Wed, 07 Mar 2018 12:32:45 +0000
How Bristol-Myers Squibb Performed in 2017

Be Sociable, Share!

Related Posts